echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > A rare intraveve tumor under the collarbone was removed in Wuhan.

    A rare intraveve tumor under the collarbone was removed in Wuhan.

    • Last Update: 2020-08-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The upper nest of the left collarbone is a good area of malignant tumor and metastatic tumor. Recently, Wuhan Concord Hospital Western Hospital vascular surgery completed a case of difficult intra-venous tumor excision, the world has not found similar tumor surgery reports.
    21-year-old female patient recently suddenly noticed a lump in her left collarbone and gradually grew. The patient has been in a number of provincial large-scale sanjia hospital, after radiation, nuclear magnetic and other examination still can not clear the lump of good malignant, and then turned to Concord Hospital West Hospital.
    the use of conservative therapy may miss the best treatment time, tumor metastasis may occur, if continued to increase, pressure or invasion of peripheral blood vessels, nerves, will increase the difficulty and risk of surgery, and finally after expert stoicism, decided to carry out surgical treatment. After more than seven hours of intensive surgery, the final operation was successfully completed.Lu Ping, executive deputy director of vascular surgery at Wuhan Concord Hospital,
    , said that the glide fibroids in the veins under the left collarbone are very rare, although it is benign tumors, but the swelling may spread to the upper cavity veins, even to the right atrium, if surgery is carried out at this time, the risk is undoubtedly greater. The patient is in good condition after surgery and has been discharged from hospital. At the same time, experts also remind the public, should improve the awareness of health check-up, early detection, early diagnosis and treatment, to avoid the development of the disease to a very serious time to re-treatment. (Zhizhi Yang Zheng)
    . All documents labeled as "Health Times Network" are original content of The Health Times, reproduced please indicate the source of "Health Times Network" and attach a link to the original text. For content collaboration, please contact 010-65369672.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.